Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Gonzalez

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelaeRyan C Thompson, Nicole W Simons, Lillian Wilkins, et al.
Nature|December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesisNelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
Nature Medicine|October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Nature Medicine|January 19, 2024
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Journal of Hepatology|December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
Cancer Research Communications|March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Nature Medicine|December 9, 2022
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelaeRyan C Thompson, Nicole W Simons, Lillian Wilkins, et al.
Research Square|March 30, 2023
Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 InfectionGirish Nadkami, Ishan Paranjpe, Pushkala Jayaraman, et al.
Blood Cancer Discovery|December 9, 2025
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myelomaDenis J Ohlstrom, William C Pilcher, Marina E Michaud, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelaeRyan C Thompson, Nicole W Simons, Lillian Wilkins, et al.
Nature|December 6, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesisNelson M LaMarche, Samarth Hegde, Matthew D Park, et al.
Nature Medicine|October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Nature Medicine|January 19, 2024
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Journal of Hepatology|December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
Cancer Research Communications|March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Nature Medicine|December 9, 2022
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelaeRyan C Thompson, Nicole W Simons, Lillian Wilkins, et al.
Research Square|March 30, 2023
Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 InfectionGirish Nadkami, Ishan Paranjpe, Pushkala Jayaraman, et al.
Blood Cancer Discovery|December 9, 2025
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myelomaDenis J Ohlstrom, William C Pilcher, Marina E Michaud, et al.
Pageof 11